EUVIMED · CrossrefZeitschrift
Gut
ISSN 0017-5749 · BMJ
Neueste Artikel
CAF-macrophage crosstalk fuels immunotherapy resistance
Dangerous intestinal disease: a case of recurrent abdominal pain with lower gastrointestinal bleeding
Gut feeling: extracellular vesicles dictate livers susceptibility to colorectal cancer metastasis
SLC6A14-mediated carnitine transmembrane uptake from PPAR? + cancer-associated fibroblasts promotes recurrence of pancreatic cancer
Artificial intelligence-tailored bowel preparation reduces laxative burden and promotes sustainable endoscopy
Chronic kidney disease in cirrhosis: a study of inpatients from a global perspective
Diet in IBD: preventive and therapeutic concepts
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease
Pancreatic cancer fibrosis activates protumorigenic Schwann cells through a nuclear mechanosensing mechanism
Proton pump inhibitors use and risk of inflammatory bowel disease in children
Endoscopic resection after neoadjuvant therapy for advanced rectal cancer with near-complete response: a retrospective multicentre case series
Role of A2 beta casein in milk-induced eosinophilic oesophagitis: novel in-vivo and in-vitro findings
Mutations of Gly277 in CPA1 -related chronic pancreatitis: clinical clues for misfolding aetiology
Tff2 marks gastric corpus progenitors that give rise to pyloric metaplasia/SPEM following injury
Safety and efficacy of extended surveillance intervals following colorectal endoscopic submucosal dissection: an international multicentre study
My first 1000 manuscript rejections
Token-guided multimodal prognosis in hepatocellular carcinoma: a framework steered by tumourstroma ratio
The UK experience with hepatitis B immunoglobulin use following liver transplantation: wide variation in practice despite evidence supporting cost-effective HBIG-free prophylaxis
Endosomal signalling of protease-activated receptor-2 amplifies histamine-induced pain of irritable bowel syndrome
Impairment of Rab7-dependent STING degradation hampers HBV replication but accelerates disease progression in chronic hepatitis B comorbid with MASLD
Steatosis severity and metabolic fingerprints after HCV eradication: toward an individualised approach to HCC surveillance after HCV cure
Helicobacter pylori infection, treatment and colorectal cancer risk by genetic predisposition: evidence from two randomised trials
Gastric microbiota-mediated immune remodelling in gastric cancer
Vascular divide: how the portal milieu shapes neutrophil activation and remote organ damage
Hepatitis B immunoglobulins after liver transplantation: essential early, optional later?
From pressure to prognosis: establishing a common language for portal hypertension in advanced chronic liver disease
GI highlights from the literature
Identification and selective inhibition of patient-specific pathobionts in inflammatory bowel disease
Shigella flexneri activates the mature DC-Tfh axis to drive tertiary lymphoid structure neogenesis and maturation in colorectal tumour microenvironments
Alcohol-induced hepatic secretome identifies the FSTL3–activin A–ActRII axis as a therapeutic target in alcohol-related liver disease
Jahrgänge
2026 · 4432025 · 3522024 · 3192023 · 3422022 · 3552021 · 3602020 · 3762019 · 3212018 · 3152017 · 3322016 · 3532015 · 4442014 · 9122013 · 1.0942012 · 1.3332011 · 9872010 · 5472009 · 3412008 · 3792007 · 4342006 · 4192005 · 4402004 · 3832003 · 4762002 · 5352001 · 4602000 · 4381999 · 4681998 · 4991997 · 4281996 · 5241995 · 5191994 · 5921993 · 5481992 · 4651991 · 4501990 · 4081989 · 4221988 · 3801987 · 412
EUVIMED